Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
PUT
Boston Scientific
BSX
$61.7B
| $108M | 0.03% |
1,128,200
+998,200
| +768% | +$97.9M |
2024 Q3
5 quarters
|
|
477
Kimberly-Clark
KMB
$31.4B
| $107M | 0.03% |
1,065,249
-228,670
| -18% | -$25M |
2013 Q2
50 quarters
|
|
478
CALL
Strategy Inc
MSTR
$63.8B
| $107M | 0.03% |
704,000
+597,800
| +563% | +$138M |
2024 Q2
6 quarters
|
|
479
M&T Bank
MTB
$31.7B
| $107M | 0.03% |
530,305
+10,120
| +2% | +$1.93M |
2013 Q2
50 quarters
|
|
480
MetLife
MET
$60B
| $107M | 0.03% |
1,350,136
-32,648
| -2% | -$2.58M |
2013 Q2
50 quarters
|
|
481
Agilent Technologies
A
$47.3B
| $106M | 0.03% |
780,761
+75,700
| +11% | +$10.9M |
2013 Q2
50 quarters
|
|
482
Arm
ARM
$328B
| $106M | 0.03% |
967,603
+307,202
| +47% | +$44.7M |
2023 Q4
8 quarters
|
|
483
Diamondback Energy
FANG
$51.7B
| $106M | 0.03% |
701,915
+48,422
| +7% | +$7.14M |
2013 Q2
50 quarters
|
|
484
Host Hotels & Resorts
HST
$15.5B
| $105M | 0.03% |
5,943,106
+3,988,127
| +204% | +$68.8M |
2013 Q2
50 quarters
|
|
485
Invitation Homes
INVH
$15.4B
| $105M | 0.03% |
3,779,586
+1,122,296
| +42% | +$31.3M |
2017 Q1
35 quarters
|
|
486
Occidental Petroleum
OXY
$58.1B
| $105M | 0.03% |
2,542,015
-447,595
| -15% | -$18.7M |
2013 Q2
50 quarters
|
|
487
Ventas
VTR
$43.1B
| $104M | 0.03% |
1,349,631
-104,908
| -7% | -$7.91M |
2013 Q2
50 quarters
|
|
488
Emerson Electric
EMR
$90.2B
| $104M | 0.03% |
786,243
-132,877
| -14% | -$17.6M |
2013 Q2
50 quarters
|
|
489
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$3.61B
| $104M | 0.03% |
1,610,000
+1,394,600
| +647% | +$87.6M |
2025 Q2
2 quarters
|
|
490
PUT
Robinhood
HOOD
$101B
| $104M | 0.03% |
920,000
+470,000
| +104% | +$61.1M |
2024 Q3
5 quarters
|
|
491
Sanofi
SNY
$95.7B
| $103M | 0.02% |
2,134,056
+485,505
| +29% | +$24.1M |
2013 Q2
50 quarters
|
|
492
Masco
MAS
$13.5B
| $103M | 0.02% |
1,624,841
+1,139,098
| +235% | +$73.9M |
2013 Q2
50 quarters
|
|
493
CALL
Chevron
CVX
$406B
| $103M | 0.02% |
676,500
-96,100
| -12% | -$14.6M |
2013 Q2
50 quarters
|
|
494
PUT
ServiceNow
NOW
$139B
| $103M | 0.02% |
673,000
+555,500
| +473% | +$95.3M |
2025 Q2
2 quarters
|
|
495
CALL
CSX Corp
CSX
$87.9B
| $103M | 0.02% |
2,843,000
+250,600
| +10% | +$8.97M |
2025 Q2
2 quarters
|
|
496
Fidelity National Information Services
FIS
$16.7B
| $103M | 0.02% |
1,547,861
-115,846
| -7% | -$7.64M |
2013 Q2
50 quarters
|
|
497
Dell
DELL
$357B
| $103M | 0.02% |
815,820
+115,278
| +16% | +$16.2M |
2016 Q3
37 quarters
|
|
498
PUT
Nutrien
NTR
$33.4B
| $102M | 0.02% |
1,660,000
+1,060,000
| +177% | +$62.4M |
2025 Q3
1 quarter
|
|
499
Carnival Corporation Ltd
CCL
$34.7B
| $102M | 0.02% |
3,337,339
+213,425
| +7% | +$5.95M |
2013 Q2
50 quarters
|
|
500
PUT
Constellation Energy
CEG
$91.3B
| $102M | 0.02% |
288,500
+35,500
| +14% | +$12.9M |
2024 Q3
5 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.